Thromboxane mediation of cardiopulmonary effects of embolism
- PMID: 6284801
- PMCID: PMC371244
- DOI: 10.1172/jci110625
Thromboxane mediation of cardiopulmonary effects of embolism
Abstract
Humoral factors released from platelets during pulmonary embolism may be the cause of several attendant cardiopulmonary abnormalities. This study examines the role of thromboxanes (Tx) after experimental embolism induced with 0.5 g/kg autologous clot in four groups of five dogs: (a) untreated embolized controls; (b) pretreatment with the Tx synthetase inhibitor, imidazole 25 mg/kg . h i.v., starting 30 min before embolization; (c) pretreatment with the cyclooxygenase inhibitor indomethacin, 5 mg/kg, 12 h per os and 1 mg/kg, 1 h i.v. before the experiment; (d) treatment with prostacyclin (PGI(2)) 100 etag/kg . min i.v. for 1 h, 1 h after embolization. Within 30 min, embolization led to increases of 6-keto-PGF(1alpha), the stable hydrolysis product of PGI(2), from 0.11+/-0.08 etag/ml (mean+/-SD) to 0.33+/-0.10 etag/ml (P < 0.005) and TxB(2), the stable product of TxA(2), from 0.10+/-0.04 etag/ml to 0.38+/-0.06 etag/ml (P < 0.001). Increases were observed in total dead space (V(D)/V(T)) from 0.46+/-0.03 to 0.61+/-0.08 (P < 0.025, physiologic shunting (Q(S)/Q(T)) from 16+/-4% to 38+/-9% (P < 0.01), pulmonary vascular resistance (PVR) from 2.27+/-0.59 mm Hg.min/liter to 9.21+/-1.90 mm Hg.min/liter (P < 0.005) and mean pulmonary arterial pressure from 14+/-6 mm Hg to 34+/-1 mm Hg (P < 0.001). Cardiac index (CI) fell from 139+/-11 ml/kg.min to 95+/-17 ml/kg.min in 4 h (P < 0.025). Imidazole pretreatment prevented a rise of TxB(2), but not 6-keto-PGF(1alpha); indomethacin blocked both. Both agents maintained V(D)/V(T) at base line and limited increases in Q(S)/Q(T) and PVR. CI was higher after imidazole pretreatment compared with controls (P < 0.025). Indomethacin led to intermediate levels of CI. PGI(2) lowered TxB(2) (P < 0.025), V(D)/V(T) (P < 0.025), Q(S)/Q(T) (P < 0.025) and PVR (P < 0.05) within 30 min. During PGI(2) infusion, CI was higher than controls. Concentrations of TxB(2) correlated with V(D)/V(T), r = 0.79 and Q(S)/Q(T), r = 0.69 (P < 0.001). Treatment of three dogs with the imidazole derivative ketoconazole, 10 mg/kg IV, 30 min after 0.75 g/kg autologous clot resulted in a lowering of physiologic dead space, but no other improvement of cardiopulmonary function. These results show that a number of cardiopulmonary abnormalities induced by pulmonary embolism are related directly or indirectly to platelet secretions and that V(D)/V(T) is closely allied to TxA(2) levels.
Similar articles
-
Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs.J Clin Invest. 1981 Aug;68(2):497-505. doi: 10.1172/jci110281. J Clin Invest. 1981. PMID: 7021593 Free PMC article.
-
Circulating negative inotropic agent(s) following pulmonary embolism.Surgery. 1982 Apr;91(4):402-8. Surgery. 1982. PMID: 6461081
-
Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.Ann Surg. 1983 Feb;197(2):220-5. doi: 10.1097/00000658-198302000-00016. Ann Surg. 1983. PMID: 6824376 Free PMC article.
-
Thromboxane mediation of cardiovascular dysfunction following aspiration.Surgery. 1983 Aug;94(2):259-66. Surgery. 1983. PMID: 6308843
-
Prostaglandin and thromboxane mediation of cardiopulmonary failure.Surg Clin North Am. 1983 Apr;63(2):263-83. doi: 10.1016/s0039-6109(16)42981-6. Surg Clin North Am. 1983. PMID: 6344273 Review. No abstract available.
Cited by
-
Effect of OKY 046, a thromboxane synthase inhibitor, on lung vascular permeability after pulmonary embolism in sheep.Thorax. 1987 Sep;42(9):676-80. doi: 10.1136/thx.42.9.676. Thorax. 1987. PMID: 3686459 Free PMC article.
-
Pulmonary vasodilation in acute pulmonary embolism - a systematic review.Pulm Circ. 2020 Mar 4;10(1):2045894019899775. doi: 10.1177/2045894019899775. eCollection 2020 Jan-Mar. Pulm Circ. 2020. PMID: 32180938 Free PMC article. Review.
-
Staphylococcal enterotoxin B initiates protein kinase C translocation and eicosanoid metabolism while inhibiting thrombin-induced aggregation in human platelets.Mol Cell Biochem. 2006 Aug;288(1-2):171-8. doi: 10.1007/s11010-006-9134-6. Epub 2006 Mar 21. Mol Cell Biochem. 2006. PMID: 16550298
-
Non-mechanical haemodynamic support in acute pulmonary thromboembolism: a scoping review.Intensive Care Med Exp. 2025 Aug 18;13(1):85. doi: 10.1186/s40635-025-00793-1. Intensive Care Med Exp. 2025. PMID: 40824356 Free PMC article. Review.
-
No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial.BMC Pulm Med. 2010 Mar 30;10:18. doi: 10.1186/1471-2466-10-18. BMC Pulm Med. 2010. PMID: 20353588 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials